Summary of Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31 Sysmex Wins Awards in 2019 Kinki Local Commendations for Innovations Sysmex and OPTiM Reach a Basic Agreement on the Establishment of a Joint Venture to Accelerate the Commercialization of Digital Medicine to Support Next-Generation Healthcare and Diagnostics Industry, Government and Academia Jointly Establish a General Incorporated Association to Promote the Bioresource Business Knowledge Is Power - Celebrating 10 Years of Sysmex Academy and More Sysmex Launches Caresphere™ QM, an Operational Support System for Testing Quality Management Sysmex Selected for Inclusion in the Dow Jones Sustainability World Index for the Fourth Consecutive Year Sysmex Europe GmbH wins the Silver Award for ‘Best Customer Training Program’ from the 2019 Brandon Hall Group Excellence in Learning Awards Japan’s First Automated Hematology Analyzer Registered by the National Museum of Nature and Science as “Essential Historical Material for Science and Technology” Hamburg leaders visited Sysmex Corporation in Kobe Liquid Biopsy performance comparison of Sysmex Inostics OncoBEAM RAS CRC and BioCartis Idylla ctKRAS testing published in Scientific Reports (Nature Journal) Sysmex R&D Center Europe Launches Joint Research with Oxford University and JVCKENWOOD to Establish a Technique for Predicting the Onset of Preeclampsia using Exosomes A welcome addition to our portfolio: Sentinel’s SENTiFOB® analyser with new cap-piercing function, ideal for low-middle throughput, for the detection of faecal occult blood using FOBGold® reagents World Anti-Doping Agency Coordinates Global Implementation of Sysmex Analyzers at All Blood Laboratories Sysmex Inostics OncoBEAM™-EGFR digital PCR liquid biopsy demonstrates two-fold higher detection of p.T790M mutations in 183 NSCLC patients in comparison study Sysmex Inostics’ SafeSEQ ER+/HER2- breast cancer panel demonstrates equivalent sensitivity to OncoBEAM™ enhanced digital PCR technology for detection of mutations in circulating tumor DNA